Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 12/2017

27.07.2017 | Review

Helicobacter pylori infection and atherosclerosis: is there a causal relationship?

verfasst von: Z. Xu, J. Li, H. Wang, G. Xu

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 12/2017

Einloggen, um Zugang zu erhalten

Abstract

For many years, the coexistence of Helicobacter pylori (H. pylori) infection and atherosclerotic diseases in a disproportional number of patients has inspired the presumption that a causal relationship exists between the conditions. This presumption was evidenced by the simultaneously declining epidemics of duodenal ulcer and coronary artery diseases in the United States in the past 40 years, and was further evidenced by the detection of H. pylori and their DNA in atherosclerotic plaques. Suggested mechanisms underlying this possible causality include intensified inflammatory stress, dyslipidemia, abnormal glucose metabolism, arterial stiffness, increased blood pressure and malnutrition. However, a causal relationship was disproved by results from other studies, which indicated that common risk factors shared by H. pylori infection and atherosclerosis, such as aging, cigarette smoking, disadvantageous socioeconomic status and high salt intake, may predestine their coexistence. Understanding the nature of the relationship between H. pylori infection and atherosclerosis is of vital importance, because a causality may indicate a possible strategy for preventing and treating atherosclerosis by eradicating H. pylori infection in selected individuals. This review assessed current evidence for and against a causal relationship between H. pylori infection and atherosclerosis.
Literatur
1.
Zurück zum Zitat Spence JD, Barnett PA, Bulman DE, Hegele RA (1999) An approach to ascertain probands with a non-traditional risk factor for carotid atherosclerosis. Atherosclerosis 144(2):429–434CrossRefPubMed Spence JD, Barnett PA, Bulman DE, Hegele RA (1999) An approach to ascertain probands with a non-traditional risk factor for carotid atherosclerosis. Atherosclerosis 144(2):429–434CrossRefPubMed
2.
Zurück zum Zitat Kumo F, Gardener H, Dong C, Cabral D, Della-Morte D, Blanton SH, Elkind MS, Sacco RL, Rundek T (2012) Traditional cardiovascular risk factors explain the minority of the variability in carotid plaque. Stroke 43(7):1755–1760CrossRef Kumo F, Gardener H, Dong C, Cabral D, Della-Morte D, Blanton SH, Elkind MS, Sacco RL, Rundek T (2012) Traditional cardiovascular risk factors explain the minority of the variability in carotid plaque. Stroke 43(7):1755–1760CrossRef
3.
Zurück zum Zitat Kurata JH, Nogawa AN (1997) Meta-analysis of risk factors for peptic ulcer. Nonsteroidal antiinflammatory drugs, Helicobacter pylori, and smoking. J Clin Gastroenterol 24(1):2–17CrossRefPubMed Kurata JH, Nogawa AN (1997) Meta-analysis of risk factors for peptic ulcer. Nonsteroidal antiinflammatory drugs, Helicobacter pylori, and smoking. J Clin Gastroenterol 24(1):2–17CrossRefPubMed
4.
Zurück zum Zitat Morris JN, Crawford MD (1958) Coronary heart disease and physical activity of work; evidence of a national necropsy survey. Br Med J 2(5111):1485–1496CrossRefPubMedPubMedCentral Morris JN, Crawford MD (1958) Coronary heart disease and physical activity of work; evidence of a national necropsy survey. Br Med J 2(5111):1485–1496CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Brooks FP, Sandweiss DJ, Long JF (1962) The relationship between peptic ulcer and coronary occlusion. Trans Am Clin Climatol Assoc 74:51–59PubMed Brooks FP, Sandweiss DJ, Long JF (1962) The relationship between peptic ulcer and coronary occlusion. Trans Am Clin Climatol Assoc 74:51–59PubMed
7.
Zurück zum Zitat Hughes WS (2014) An hypothesis: the dramatic decline in heart attacks in the United States is temporally related to the decline in duodenal ulcer disease and Helicobacter pylori infection. Helicobacter 19(3):239–241CrossRefPubMed Hughes WS (2014) An hypothesis: the dramatic decline in heart attacks in the United States is temporally related to the decline in duodenal ulcer disease and Helicobacter pylori infection. Helicobacter 19(3):239–241CrossRefPubMed
8.
Zurück zum Zitat Cheng TJ, Guo HR, Chang CY, Weng SF, Li PI, Wang JJ, Wu WS (2016) The association between peptic ulcer disease and ischemic stroke: a population-based longitudinal study. Medicine 95(22):e3797CrossRefPubMedPubMedCentral Cheng TJ, Guo HR, Chang CY, Weng SF, Li PI, Wang JJ, Wu WS (2016) The association between peptic ulcer disease and ischemic stroke: a population-based longitudinal study. Medicine 95(22):e3797CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D, Camm AJ, Northfield TC (1994) Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 71(5):437–439CrossRefPubMedPubMedCentral Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D, Camm AJ, Northfield TC (1994) Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 71(5):437–439CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Akyön YPA, Farsak B, Böke E, Günalp A (1999) H. pylori and Chlamydia pneumoniae DNA found in atherosclerotic plaques by polymerase chain reaction. Gut 45:A89CrossRef Akyön YPA, Farsak B, Böke E, Günalp A (1999) H. pylori and Chlamydia pneumoniae DNA found in atherosclerotic plaques by polymerase chain reaction. Gut 45:A89CrossRef
11.
Zurück zum Zitat Ameriso SF, Fridman EA, Leiguarda RC, Sevlever GE (2001) Detection of Helicobacter pylori in human carotid atherosclerotic plaques. Stroke 32(2):385–391CrossRefPubMed Ameriso SF, Fridman EA, Leiguarda RC, Sevlever GE (2001) Detection of Helicobacter pylori in human carotid atherosclerotic plaques. Stroke 32(2):385–391CrossRefPubMed
12.
Zurück zum Zitat Kowalski M, Rees W, Konturek PC, Grove R, Scheffold T, Meixner H, Brunec M, Franz N, Konturek JW, Pieniazek P, Hahn EG, Konturek SJ, Thale J, Warnecke H (2002) Detection of Helicobacter pylori specific DNA in human atheromatous coronary arteries and its association to prior myocardial infarction and unstable angina. Dig Liver Dis 34(6):398–402CrossRefPubMed Kowalski M, Rees W, Konturek PC, Grove R, Scheffold T, Meixner H, Brunec M, Franz N, Konturek JW, Pieniazek P, Hahn EG, Konturek SJ, Thale J, Warnecke H (2002) Detection of Helicobacter pylori specific DNA in human atheromatous coronary arteries and its association to prior myocardial infarction and unstable angina. Dig Liver Dis 34(6):398–402CrossRefPubMed
13.
Zurück zum Zitat Kaplan M, Yavuz SS, Cinar B, Koksal V, Kut MS, Yapici F, Gercekoglu H, Demirtas MM (2006) Detection of Chlamydia pneumoniae and Helicobacter pylori in atherosclerotic plaques of carotid artery by polymerase chain reaction. Int J Infect Dis 10(2):116–123CrossRefPubMed Kaplan M, Yavuz SS, Cinar B, Koksal V, Kut MS, Yapici F, Gercekoglu H, Demirtas MM (2006) Detection of Chlamydia pneumoniae and Helicobacter pylori in atherosclerotic plaques of carotid artery by polymerase chain reaction. Int J Infect Dis 10(2):116–123CrossRefPubMed
14.
Zurück zum Zitat Kilic A, Onguru O, Tugcu H, Kilic S, Guney C, Bilge Y (2006) Detection of cytomegalovirus and Helicobacter pylori DNA in arterial walls with grade III atherosclerosis by PCR. Pol J Microbiol 55(4):333–337PubMed Kilic A, Onguru O, Tugcu H, Kilic S, Guney C, Bilge Y (2006) Detection of cytomegalovirus and Helicobacter pylori DNA in arterial walls with grade III atherosclerosis by PCR. Pol J Microbiol 55(4):333–337PubMed
15.
Zurück zum Zitat Xu Y, Wang Q, Liu Y, Cui R, Lu K, Zhao Y (2016) Association between Helicobacter pylori infection and carotid atherosclerosis in patients with vascular dementia. J Neurol Sci 362:73–77CrossRefPubMed Xu Y, Wang Q, Liu Y, Cui R, Lu K, Zhao Y (2016) Association between Helicobacter pylori infection and carotid atherosclerosis in patients with vascular dementia. J Neurol Sci 362:73–77CrossRefPubMed
16.
Zurück zum Zitat Diomedi M, Pietroiusti A, Silvestrini M, Rizzato B, Cupini LM, Ferrante F, Magrini A, Bergamaschi A, Galante A, Bernardi G (2004) CagA-positive Helicobacter pylori strains may influence the natural history of atherosclerotic stroke. Neurology 63(5):800–804CrossRefPubMed Diomedi M, Pietroiusti A, Silvestrini M, Rizzato B, Cupini LM, Ferrante F, Magrini A, Bergamaschi A, Galante A, Bernardi G (2004) CagA-positive Helicobacter pylori strains may influence the natural history of atherosclerotic stroke. Neurology 63(5):800–804CrossRefPubMed
17.
Zurück zum Zitat Elkind MS, Luna JM, Moon YP, Boden-Albala B, Liu KM, Spitalnik S, Rundek T, Sacco RL, Paik MC (2010) Infectious burden and carotid plaque thickness: the northern Manhattan study. Stroke 41(3):e117–e122CrossRefPubMedPubMedCentral Elkind MS, Luna JM, Moon YP, Boden-Albala B, Liu KM, Spitalnik S, Rundek T, Sacco RL, Paik MC (2010) Infectious burden and carotid plaque thickness: the northern Manhattan study. Stroke 41(3):e117–e122CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Shmuely H, Wattad M, Solodky A, Yahav J, Samra Z, Zafrir N (2014) Association of Helicobacter pylori with coronary artery disease and myocardial infarction assessed by myocardial perfusion imaging. Isr Med Assoc J 16(6):341–346PubMed Shmuely H, Wattad M, Solodky A, Yahav J, Samra Z, Zafrir N (2014) Association of Helicobacter pylori with coronary artery disease and myocardial infarction assessed by myocardial perfusion imaging. Isr Med Assoc J 16(6):341–346PubMed
19.
Zurück zum Zitat Lai CY, Yang TY, Lin CL, Kao CH (2015) Helicobacter pylori infection and the risk of acute coronary syndrome: a nationwide retrospective cohort study. Eur J Clin Microbiol Infect Dis 34(1):69–74CrossRefPubMed Lai CY, Yang TY, Lin CL, Kao CH (2015) Helicobacter pylori infection and the risk of acute coronary syndrome: a nationwide retrospective cohort study. Eur J Clin Microbiol Infect Dis 34(1):69–74CrossRefPubMed
20.
Zurück zum Zitat Franceschi F, Niccoli G, Ferrante G, Gasbarrini A, Baldi A, Candelli M, Feroce F, Saulnier N, Conte M, Roccarina D, Lanza GA, Gasbarrini G, Gentiloni SN, Crea F (2009) CagA antigen of Helicobacter pylori and coronary instability: insight from a clinico-pathological study and a meta-analysis of 4241 cases. Atherosclerosis 202(2):535–542CrossRefPubMed Franceschi F, Niccoli G, Ferrante G, Gasbarrini A, Baldi A, Candelli M, Feroce F, Saulnier N, Conte M, Roccarina D, Lanza GA, Gasbarrini G, Gentiloni SN, Crea F (2009) CagA antigen of Helicobacter pylori and coronary instability: insight from a clinico-pathological study and a meta-analysis of 4241 cases. Atherosclerosis 202(2):535–542CrossRefPubMed
21.
Zurück zum Zitat Liu J, Wang F, Shi S (2015) Helicobacter pylori infection increase the risk of myocardial infarction: a meta-analysis of 26 studies involving more than 20,000 participants. Helicobacter 20(3):176–183CrossRefPubMed Liu J, Wang F, Shi S (2015) Helicobacter pylori infection increase the risk of myocardial infarction: a meta-analysis of 26 studies involving more than 20,000 participants. Helicobacter 20(3):176–183CrossRefPubMed
22.
Zurück zum Zitat Sun J, Rangan P, Bhat SS, Liu L (2016) A meta-analysis of the association between Helicobacter pylori infection and risk of coronary heart disease from published prospective studies. Helicobacter 21(1):11–23CrossRefPubMed Sun J, Rangan P, Bhat SS, Liu L (2016) A meta-analysis of the association between Helicobacter pylori infection and risk of coronary heart disease from published prospective studies. Helicobacter 21(1):11–23CrossRefPubMed
23.
Zurück zum Zitat Pietroiusti A, Diomedi M, Silvestrini M, Cupini LM, Luzzi I, Gomez-Miguel MJ, Bergamaschi A, Magrini A, Carrabs T, Vellini M, Galante A (2002) Cytotoxin-associated gene-A--positive Helicobacter pylori strains are associated with atherosclerotic stroke. Circulation 106(5):580–584CrossRefPubMed Pietroiusti A, Diomedi M, Silvestrini M, Cupini LM, Luzzi I, Gomez-Miguel MJ, Bergamaschi A, Magrini A, Carrabs T, Vellini M, Galante A (2002) Cytotoxin-associated gene-A--positive Helicobacter pylori strains are associated with atherosclerotic stroke. Circulation 106(5):580–584CrossRefPubMed
24.
Zurück zum Zitat Diomedi M, Stanzione P, Sallustio F, Leone G, Renna A, Misaggi G, Fontana C, Pasqualetti P, Pietroiusti A (2008) Cytotoxin-associated Gene-A-positive Helicobacter pylori strains infection increases the risk of recurrent atherosclerotic stroke. Helicobacter 13(6):525–531CrossRefPubMed Diomedi M, Stanzione P, Sallustio F, Leone G, Renna A, Misaggi G, Fontana C, Pasqualetti P, Pietroiusti A (2008) Cytotoxin-associated Gene-A-positive Helicobacter pylori strains infection increases the risk of recurrent atherosclerotic stroke. Helicobacter 13(6):525–531CrossRefPubMed
25.
Zurück zum Zitat Markus HS, Mendall MA (1998) Helicobacter pylori infection: a risk factor for ischaemic cerebrovascular disease and carotid atheroma. J Neurol Neurosurg Psychiatry 64(1):104–107CrossRefPubMedPubMedCentral Markus HS, Mendall MA (1998) Helicobacter pylori infection: a risk factor for ischaemic cerebrovascular disease and carotid atheroma. J Neurol Neurosurg Psychiatry 64(1):104–107CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Heuschmann PU, Neureiter D, Gesslein M, Craiovan B, Maass M, Faller G, Beck G, Neundoerfer B, Kolominsky-Rabas PL (2001) Association between infection with Helicobacter pylori and Chlamydia pneumoniae and risk of ischemic stroke subtypes: results from a population-based case-control study. Stroke 32(10):2253–2258CrossRefPubMed Heuschmann PU, Neureiter D, Gesslein M, Craiovan B, Maass M, Faller G, Beck G, Neundoerfer B, Kolominsky-Rabas PL (2001) Association between infection with Helicobacter pylori and Chlamydia pneumoniae and risk of ischemic stroke subtypes: results from a population-based case-control study. Stroke 32(10):2253–2258CrossRefPubMed
27.
Zurück zum Zitat Kowalski M (2001) Helicobacter pylori (H. Pylori) infection in coronary artery disease: influence of H. Pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. Pylori specific DNA in human coronary atherosclerotic plaque. J Physiol Pharmacol 52(1 Suppl 1):3–31PubMed Kowalski M (2001) Helicobacter pylori (H. Pylori) infection in coronary artery disease: influence of H. Pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. Pylori specific DNA in human coronary atherosclerotic plaque. J Physiol Pharmacol 52(1 Suppl 1):3–31PubMed
28.
Zurück zum Zitat Kowalski M, Konturek PC, Pieniazek P, Karczewska E, Kluczka A, Grove R, Kranig W, Nasseri R, Thale J, Hahn EG, Konturek SJ (2001) Prevalence of Helicobacter pylori infection in coronary artery disease and effect of its eradication on coronary lumen reduction after percutaneous coronary angioplasty. Dig Liver Dis 33(3):222–229CrossRefPubMed Kowalski M, Konturek PC, Pieniazek P, Karczewska E, Kluczka A, Grove R, Kranig W, Nasseri R, Thale J, Hahn EG, Konturek SJ (2001) Prevalence of Helicobacter pylori infection in coronary artery disease and effect of its eradication on coronary lumen reduction after percutaneous coronary angioplasty. Dig Liver Dis 33(3):222–229CrossRefPubMed
29.
Zurück zum Zitat Pellicano R, Oliaro E, Fagoonee S, Astegiano M, Berrutti M, Saracco G, Smedile A, Repici A, Leone N, Castelli A, Luigiano C, Fadda M, Rizzetto M (2009) Clinical and biochemical parameters related to cardiovascular disease after Helicobacter pylori eradication. Int Angiol 28(6):469–473PubMed Pellicano R, Oliaro E, Fagoonee S, Astegiano M, Berrutti M, Saracco G, Smedile A, Repici A, Leone N, Castelli A, Luigiano C, Fadda M, Rizzetto M (2009) Clinical and biochemical parameters related to cardiovascular disease after Helicobacter pylori eradication. Int Angiol 28(6):469–473PubMed
30.
Zurück zum Zitat Coronado MT, Pozzi AO, Punchard MA, Gonzalez P, Fantidis P (2009) Inflammation as a modulator of the HDL cholesterol-induced inteleukin-10 production by human circulating mononuclear cells. Atherosclerosis 202(1):183–184CrossRefPubMed Coronado MT, Pozzi AO, Punchard MA, Gonzalez P, Fantidis P (2009) Inflammation as a modulator of the HDL cholesterol-induced inteleukin-10 production by human circulating mononuclear cells. Atherosclerosis 202(1):183–184CrossRefPubMed
31.
Zurück zum Zitat Gen R, Demir M, Ataseven H (2010) Effect of Helicobacter pylori eradication on insulin resistance, serum lipids and low-grade inflammation. South Med J 103(3):190–196CrossRefPubMed Gen R, Demir M, Ataseven H (2010) Effect of Helicobacter pylori eradication on insulin resistance, serum lipids and low-grade inflammation. South Med J 103(3):190–196CrossRefPubMed
32.
Zurück zum Zitat Kanbay M, Gur G, Yucel M, Yilmaz U, Boyacioglu S (2005) Does eradication of Helicobacter pylori infection help normalize serum lipid and CRP levels? Dig Dis Sci 50(7):1228–1231CrossRefPubMed Kanbay M, Gur G, Yucel M, Yilmaz U, Boyacioglu S (2005) Does eradication of Helicobacter pylori infection help normalize serum lipid and CRP levels? Dig Dis Sci 50(7):1228–1231CrossRefPubMed
33.
Zurück zum Zitat Grayston JT, Kronmal RA, Jackson LA, Parisi AF, Muhlestein JB, Cohen JD, Rogers WJ, Crouse JR, Borrowdale SL, Schron E, Knirsch C, Investigators A (2005) Azithromycin for the secondary prevention of coronary events. N Engl J Med 352(16):1637–1645CrossRefPubMed Grayston JT, Kronmal RA, Jackson LA, Parisi AF, Muhlestein JB, Cohen JD, Rogers WJ, Crouse JR, Borrowdale SL, Schron E, Knirsch C, Investigators A (2005) Azithromycin for the secondary prevention of coronary events. N Engl J Med 352(16):1637–1645CrossRefPubMed
34.
Zurück zum Zitat Algood HM, Cover TL (2006) Helicobacter pylori persistence: an overview of interactions between H. pylori and host immune defenses. Clin Microbiol Rev 19(4):597–613CrossRefPubMedPubMedCentral Algood HM, Cover TL (2006) Helicobacter pylori persistence: an overview of interactions between H. pylori and host immune defenses. Clin Microbiol Rev 19(4):597–613CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Tamer GS, Tengiz I, Ercan E, Duman C, Alioglu E, Turk UO (2009) Helicobacter pylori seropositivity in patients with acute coronary syndromes. Dig Dis Sci 54(6):1253–1256CrossRefPubMed Tamer GS, Tengiz I, Ercan E, Duman C, Alioglu E, Turk UO (2009) Helicobacter pylori seropositivity in patients with acute coronary syndromes. Dig Dis Sci 54(6):1253–1256CrossRefPubMed
37.
Zurück zum Zitat Crowe SE, Alvarez L, Dytoc M, Hunt RH, Muller M, Sherman P, Patel J, Jin Y, Ernst PB (1995) Expression of interleukin 8 and CD54 by human gastric epithelium after Helicobacter pylori infection in vitro. Gastroenterology 108(1):65–74CrossRefPubMed Crowe SE, Alvarez L, Dytoc M, Hunt RH, Muller M, Sherman P, Patel J, Jin Y, Ernst PB (1995) Expression of interleukin 8 and CD54 by human gastric epithelium after Helicobacter pylori infection in vitro. Gastroenterology 108(1):65–74CrossRefPubMed
38.
Zurück zum Zitat Alvarez-Arellano L, Maldonado-Bernal C (2014) Helicobacter pylori and neurological diseases: married by the laws of inflammation. World J Gastrointest Pathophysiol 5(4):400–404CrossRefPubMedPubMedCentral Alvarez-Arellano L, Maldonado-Bernal C (2014) Helicobacter pylori and neurological diseases: married by the laws of inflammation. World J Gastrointest Pathophysiol 5(4):400–404CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Xu Y, Wang Q, Liu Y, Cui R, Zhao Y (2016) Is Helicobacter pylori infection a critical risk factor for vascular dementia? Int J Neurosci 126(10):899–903CrossRefPubMed Xu Y, Wang Q, Liu Y, Cui R, Zhao Y (2016) Is Helicobacter pylori infection a critical risk factor for vascular dementia? Int J Neurosci 126(10):899–903CrossRefPubMed
40.
Zurück zum Zitat Consolazio A, Borgia MC, Ferro D, Iacopini F, Paoluzi OA, Crispino P, Nardi F, Rivera M, Paoluzi P (2004) Increased thrombin generation and circulating levels of tumour necrosis factor-alpha in patients with chronic Helicobacter pylori-positive gastritis. Aliment Pharmacol Ther 20(3):289–294CrossRefPubMed Consolazio A, Borgia MC, Ferro D, Iacopini F, Paoluzi OA, Crispino P, Nardi F, Rivera M, Paoluzi P (2004) Increased thrombin generation and circulating levels of tumour necrosis factor-alpha in patients with chronic Helicobacter pylori-positive gastritis. Aliment Pharmacol Ther 20(3):289–294CrossRefPubMed
41.
Zurück zum Zitat Cid TP, Fernandez MC, Benito Martinez S, Jones NL (2013) Pathogenesis of Helicobacter pylori infection. Helicobacter 18(Suppl 1):12–17CrossRefPubMed Cid TP, Fernandez MC, Benito Martinez S, Jones NL (2013) Pathogenesis of Helicobacter pylori infection. Helicobacter 18(Suppl 1):12–17CrossRefPubMed
43.
Zurück zum Zitat Oshima T, Ozono R, Yano Y, Oishi Y, Teragawa H, Higashi Y, Yoshizumi M, Kambe M (2005) Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects. J Am Coll Cardiol 45(8):1219–1222CrossRefPubMed Oshima T, Ozono R, Yano Y, Oishi Y, Teragawa H, Higashi Y, Yoshizumi M, Kambe M (2005) Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects. J Am Coll Cardiol 45(8):1219–1222CrossRefPubMed
44.
Zurück zum Zitat Vitale G, Barbaro F, Ianiro G, Cesario V, Gasbarrini G, Franceschi F, Gasbarrini A (2011) Nutritional aspects of Helicobacter pylori infection. Minerva Gastroenterol Dietol 57(4):369–377PubMed Vitale G, Barbaro F, Ianiro G, Cesario V, Gasbarrini G, Franceschi F, Gasbarrini A (2011) Nutritional aspects of Helicobacter pylori infection. Minerva Gastroenterol Dietol 57(4):369–377PubMed
45.
Zurück zum Zitat Sipponen P, Laxen F, Huotari K, Harkonen M (2003) Prevalence of low vitamin B12 and high homocysteine in serum in an elderly male population: association with atrophic gastritis and Helicobacter pylori infection. Scand J Gastroenterol 38(12):1209–1216CrossRefPubMed Sipponen P, Laxen F, Huotari K, Harkonen M (2003) Prevalence of low vitamin B12 and high homocysteine in serum in an elderly male population: association with atrophic gastritis and Helicobacter pylori infection. Scand J Gastroenterol 38(12):1209–1216CrossRefPubMed
46.
Zurück zum Zitat Evrengul H, Tanriverdi H, Kuru O, Enli Y, Yuksel D, Kilic A, Kaftan A, Kirac S, Kilic M (2007) Elevated homocysteine levels in patients with slow coronary flow: relationship with Helicobacter pylori infection. Helicobacter 12(4):298–305CrossRefPubMed Evrengul H, Tanriverdi H, Kuru O, Enli Y, Yuksel D, Kilic A, Kaftan A, Kirac S, Kilic M (2007) Elevated homocysteine levels in patients with slow coronary flow: relationship with Helicobacter pylori infection. Helicobacter 12(4):298–305CrossRefPubMed
47.
Zurück zum Zitat Laurila A, Bloigu A, Nayha S, Hassi J, Leinonen M, Saikku P (1999) Association of Helicobacter pylori infection with elevated serum lipids. Atherosclerosis 142(1):207–210CrossRefPubMed Laurila A, Bloigu A, Nayha S, Hassi J, Leinonen M, Saikku P (1999) Association of Helicobacter pylori infection with elevated serum lipids. Atherosclerosis 142(1):207–210CrossRefPubMed
48.
Zurück zum Zitat Ansorg R, Muller KD, von Recklinghausen G, Nalik HP (1992) Cholesterol binding of Helicobacter pylori. Zentralbl Bakteriol 276(3):323–329CrossRefPubMed Ansorg R, Muller KD, von Recklinghausen G, Nalik HP (1992) Cholesterol binding of Helicobacter pylori. Zentralbl Bakteriol 276(3):323–329CrossRefPubMed
49.
Zurück zum Zitat Elizalde JI, Pique JM, Moreno V, Morillas JD, Elizalde I, Bujanda L, De Argila CM, Cosme A, Castiella A, Ros E, Group of Study on O, Gastric Diseases from The Spanish Gastroenterological A (2002) Influence of Helicobacter pylori infection and eradication on blood lipids and fibrinogen. Aliment Pharmacol Ther 16(3):577–586CrossRefPubMed Elizalde JI, Pique JM, Moreno V, Morillas JD, Elizalde I, Bujanda L, De Argila CM, Cosme A, Castiella A, Ros E, Group of Study on O, Gastric Diseases from The Spanish Gastroenterological A (2002) Influence of Helicobacter pylori infection and eradication on blood lipids and fibrinogen. Aliment Pharmacol Ther 16(3):577–586CrossRefPubMed
50.
Zurück zum Zitat Devrajani BR, Shah SZ, Soomro AA, Devrajani T (2010) Type 2 diabetes mellitus: a risk factor for Helicobacter pylori infection: a hospital based case-control study. Int J Diabetes Dev Ctries 30(1):22–26CrossRefPubMedPubMedCentral Devrajani BR, Shah SZ, Soomro AA, Devrajani T (2010) Type 2 diabetes mellitus: a risk factor for Helicobacter pylori infection: a hospital based case-control study. Int J Diabetes Dev Ctries 30(1):22–26CrossRefPubMedPubMedCentral
51.
Zurück zum Zitat Hsieh MC, Wang SS, Hsieh YT, Kuo FC, Soon MS, Wu DC (2013) Helicobacter pylori infection associated with high HbA1c and type 2 diabetes. Eur J Clin Investig 43(9):949–956CrossRef Hsieh MC, Wang SS, Hsieh YT, Kuo FC, Soon MS, Wu DC (2013) Helicobacter pylori infection associated with high HbA1c and type 2 diabetes. Eur J Clin Investig 43(9):949–956CrossRef
52.
53.
Zurück zum Zitat Demir M, Gokturk HS, Ozturk NA, Kulaksizoglu M, Serin E, Yilmaz U (2008) Helicobacter pylori prevalence in diabetes mellitus patients with dyspeptic symptoms and its relationship to glycemic control and late complications. Dig Dis Sci 53(10):2646–2649CrossRefPubMed Demir M, Gokturk HS, Ozturk NA, Kulaksizoglu M, Serin E, Yilmaz U (2008) Helicobacter pylori prevalence in diabetes mellitus patients with dyspeptic symptoms and its relationship to glycemic control and late complications. Dig Dis Sci 53(10):2646–2649CrossRefPubMed
54.
Zurück zum Zitat Hopkins KD, Lehmann ED, Gosling RG (1994) Aortic compliance measurements: a non-invasive indicator of atherosclerosis? Lancet 343(8911):1447CrossRefPubMed Hopkins KD, Lehmann ED, Gosling RG (1994) Aortic compliance measurements: a non-invasive indicator of atherosclerosis? Lancet 343(8911):1447CrossRefPubMed
55.
Zurück zum Zitat Evans PH (1965) Relation of longstanding blood-pressure levels to atherosclerosis. Lancet 1(7384):516–519CrossRefPubMed Evans PH (1965) Relation of longstanding blood-pressure levels to atherosclerosis. Lancet 1(7384):516–519CrossRefPubMed
56.
Zurück zum Zitat Adachi K, Arima N, Takashima T, Miyaoka Y, Yuki M, Ono M, Komazawa Y, Kawamura A, Fujishiro H, Ishihara S, Kinoshita Y (2003) Pulse-wave velocity and cardiovascular risk factors in subjects with Helicobacter pylori infection. J Gastroenterol Hepatol 18(7):771–777CrossRefPubMed Adachi K, Arima N, Takashima T, Miyaoka Y, Yuki M, Ono M, Komazawa Y, Kawamura A, Fujishiro H, Ishihara S, Kinoshita Y (2003) Pulse-wave velocity and cardiovascular risk factors in subjects with Helicobacter pylori infection. J Gastroenterol Hepatol 18(7):771–777CrossRefPubMed
57.
Zurück zum Zitat Yoshikawa H, Aida K, Mori A, Muto S, Fukuda T (2007) Involvement of Helicobacter pylori infection and impaired glucose metabolism in the increase of brachial-ankle pulse wave velocity. Helicobacter 12(5):559–566CrossRefPubMed Yoshikawa H, Aida K, Mori A, Muto S, Fukuda T (2007) Involvement of Helicobacter pylori infection and impaired glucose metabolism in the increase of brachial-ankle pulse wave velocity. Helicobacter 12(5):559–566CrossRefPubMed
58.
Zurück zum Zitat Lip GH, Wise R, Beevers G (1996) Association of Helicobacter pylori infection with coronary heart disease. Study shows association between H pylori infection and hypertension. BMJ 312(7025):250–251CrossRefPubMedPubMedCentral Lip GH, Wise R, Beevers G (1996) Association of Helicobacter pylori infection with coronary heart disease. Study shows association between H pylori infection and hypertension. BMJ 312(7025):250–251CrossRefPubMedPubMedCentral
59.
Zurück zum Zitat Migneco A, Ojetti V, Specchia L, Franceschi F, Candelli M, Mettimano M, Montebelli R, Savi L, Gasbarrini G (2003) Eradication of Helicobacter pylori infection improves blood pressure values in patients affected by hypertension. Helicobacter 8(6):585–589CrossRefPubMed Migneco A, Ojetti V, Specchia L, Franceschi F, Candelli M, Mettimano M, Montebelli R, Savi L, Gasbarrini G (2003) Eradication of Helicobacter pylori infection improves blood pressure values in patients affected by hypertension. Helicobacter 8(6):585–589CrossRefPubMed
60.
Zurück zum Zitat Gerig R, Ernst B, Wilms B, Thurnheer M, Schultes B (2013) Preoperative nutritional deficiencies in severely obese bariatric candidates are not linked to gastric Helicobacter pylori infection. Obes Surg 23(5):698–702CrossRefPubMed Gerig R, Ernst B, Wilms B, Thurnheer M, Schultes B (2013) Preoperative nutritional deficiencies in severely obese bariatric candidates are not linked to gastric Helicobacter pylori infection. Obes Surg 23(5):698–702CrossRefPubMed
61.
Zurück zum Zitat Nelson JJ, Liao D, Sharrett AR, Folsom AR, Chambless LE, Shahar E, Szklo M, Eckfeldt J, Heiss G (2000) Serum albumin level as a predictor of incident coronary heart disease: the atherosclerosis risk in Communities (ARIC) study. Am J Epidemiol 151(5):468–477CrossRefPubMed Nelson JJ, Liao D, Sharrett AR, Folsom AR, Chambless LE, Shahar E, Szklo M, Eckfeldt J, Heiss G (2000) Serum albumin level as a predictor of incident coronary heart disease: the atherosclerosis risk in Communities (ARIC) study. Am J Epidemiol 151(5):468–477CrossRefPubMed
62.
Zurück zum Zitat Sarnak MJ, Tighiouart H, Manjunath G, MacLeod B, Griffith J, Salem D, Levey AS (2002) Anemia as a risk factor for cardiovascular disease in the atherosclerosis risk in Communities (ARIC) study. J Am Coll Cardiol 40(1):27–33CrossRefPubMed Sarnak MJ, Tighiouart H, Manjunath G, MacLeod B, Griffith J, Salem D, Levey AS (2002) Anemia as a risk factor for cardiovascular disease in the atherosclerosis risk in Communities (ARIC) study. J Am Coll Cardiol 40(1):27–33CrossRefPubMed
63.
Zurück zum Zitat Alcazar Lazaro V, del Ser QT, Barba Martin R (2013) Hypoalbuminemia and other prognostic factors of mortality at different time points after ischemic stroke. Nutr Hosp 28(2):456–463PubMed Alcazar Lazaro V, del Ser QT, Barba Martin R (2013) Hypoalbuminemia and other prognostic factors of mortality at different time points after ischemic stroke. Nutr Hosp 28(2):456–463PubMed
64.
Zurück zum Zitat Alvarez-Perez FJ, Castelo-Branco M, Alvarez-Sabin J (2011) Albumin level and stroke. Potential association between lower albumin level and cardioembolic aetiology. Int J Neurosci 121(1):25–32CrossRefPubMed Alvarez-Perez FJ, Castelo-Branco M, Alvarez-Sabin J (2011) Albumin level and stroke. Potential association between lower albumin level and cardioembolic aetiology. Int J Neurosci 121(1):25–32CrossRefPubMed
65.
Zurück zum Zitat Dijk JM, Wangge G, Graaf Y, Bots ML, Grobbee DE, Algra A, Group SM-S (2006) Hemoglobin and atherosclerosis in patients with manifest arterial disease. The SMART-study. Atherosclerosis 188(2):444–449CrossRefPubMed Dijk JM, Wangge G, Graaf Y, Bots ML, Grobbee DE, Algra A, Group SM-S (2006) Hemoglobin and atherosclerosis in patients with manifest arterial disease. The SMART-study. Atherosclerosis 188(2):444–449CrossRefPubMed
66.
Zurück zum Zitat Qu XH, Huang XL, Xiong P, Zhu CY, Huang YL, Lu LG, Sun X, Rong L, Zhong L, Sun DY, Lin H, Cai MC, Chen ZW, Hu B, Wu LM, Jiang YB, Yan WL (2010) Does Helicobacter pylori infection play a role in iron deficiency anemia? A meta-analysis. World J Gastroenterol 16(7):886–896PubMedPubMedCentral Qu XH, Huang XL, Xiong P, Zhu CY, Huang YL, Lu LG, Sun X, Rong L, Zhong L, Sun DY, Lin H, Cai MC, Chen ZW, Hu B, Wu LM, Jiang YB, Yan WL (2010) Does Helicobacter pylori infection play a role in iron deficiency anemia? A meta-analysis. World J Gastroenterol 16(7):886–896PubMedPubMedCentral
67.
Zurück zum Zitat Huang X, Qu X, Yan W, Huang Y, Cai M, Hu B, Wu L, Lin H, Chen Z, Zhu C, Lu L, Sun X, Rong L, Jiang Y, Sun D, Zhong L, Xiong P (2010) Iron deficiency anaemia can be improved after eradication of Helicobacter pylori. Postgrad Med J 86(1015):272–278CrossRefPubMedPubMedCentral Huang X, Qu X, Yan W, Huang Y, Cai M, Hu B, Wu L, Lin H, Chen Z, Zhu C, Lu L, Sun X, Rong L, Jiang Y, Sun D, Zhong L, Xiong P (2010) Iron deficiency anaemia can be improved after eradication of Helicobacter pylori. Postgrad Med J 86(1015):272–278CrossRefPubMedPubMedCentral
68.
Zurück zum Zitat Ferrucci L, Guralnik JM, Woodman RC, Bandinelli S, Lauretani F, Corsi AM, Chaves PH, Ershler WB, Longo DL (2005) Proinflammatory state and circulating erythropoietin in persons with and without anemia. Am J Med 118(11):1288CrossRefPubMed Ferrucci L, Guralnik JM, Woodman RC, Bandinelli S, Lauretani F, Corsi AM, Chaves PH, Ershler WB, Longo DL (2005) Proinflammatory state and circulating erythropoietin in persons with and without anemia. Am J Med 118(11):1288CrossRefPubMed
69.
Zurück zum Zitat Saito M, Morioka M, Wakasa K, Izumiyama K, Mori A, Irie T, Tanaka M, Tanaka S (2013) In Japanese patients with type a gastritis with pernicious anemia the condition is very poorly associated with Helicobacter pylori infection. J Infect Chemother 19(2):208–210CrossRefPubMed Saito M, Morioka M, Wakasa K, Izumiyama K, Mori A, Irie T, Tanaka M, Tanaka S (2013) In Japanese patients with type a gastritis with pernicious anemia the condition is very poorly associated with Helicobacter pylori infection. J Infect Chemother 19(2):208–210CrossRefPubMed
70.
Zurück zum Zitat Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D, Northfield TC (1992) Childhood living conditions and Helicobacter pylori seropositivity in adult life. Lancet 339(8798):896–897CrossRefPubMed Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D, Northfield TC (1992) Childhood living conditions and Helicobacter pylori seropositivity in adult life. Lancet 339(8798):896–897CrossRefPubMed
71.
Zurück zum Zitat Malaty HM, Paykov V, Bykova O, Ross A, Graham DP, Anneger JF, Graham DY (1996) Helicobacter pylori and socioeconomic factors in Russia. Helicobacter 1(2):82–87CrossRefPubMed Malaty HM, Paykov V, Bykova O, Ross A, Graham DP, Anneger JF, Graham DY (1996) Helicobacter pylori and socioeconomic factors in Russia. Helicobacter 1(2):82–87CrossRefPubMed
72.
Zurück zum Zitat Johnsen R, Forde OH, Straume B, Burhol PG (1994) Aetiology of peptic ulcer: a prospective population study in Norway. J Epidemiol Community Health 48(2):156–160CrossRefPubMedPubMedCentral Johnsen R, Forde OH, Straume B, Burhol PG (1994) Aetiology of peptic ulcer: a prospective population study in Norway. J Epidemiol Community Health 48(2):156–160CrossRefPubMedPubMedCentral
73.
Zurück zum Zitat Whitaker CJ, Dubiel AJ, Galpin OP (1993) Social and geographical risk factors in Helicobacter pylori infection. Epidemiol Infect 111 (1):63–70 Whitaker CJ, Dubiel AJ, Galpin OP (1993) Social and geographical risk factors in Helicobacter pylori infection. Epidemiol Infect 111 (1):63–70
74.
Zurück zum Zitat Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L, Investigators IS (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364(9438):937–952CrossRefPubMed Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L, Investigators IS (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364(9438):937–952CrossRefPubMed
75.
Zurück zum Zitat Bures J, Kopacova M, Skodova Fendrichova M, Rejchrt S (2011) Epidemiology of Helicobacter pylori infection. Vnitrni lekarstvi 57(12):993–999PubMed Bures J, Kopacova M, Skodova Fendrichova M, Rejchrt S (2011) Epidemiology of Helicobacter pylori infection. Vnitrni lekarstvi 57(12):993–999PubMed
76.
Zurück zum Zitat Howard G, Wagenknecht LE, Burke GL, Diez-Roux A, Evans GW, McGovern P, Nieto FJ, Tell GS (1998) Cigarette smoking and progression of atherosclerosis: the atherosclerosis risk in Communities (ARIC) study. JAMA 279(2):119–124CrossRefPubMed Howard G, Wagenknecht LE, Burke GL, Diez-Roux A, Evans GW, McGovern P, Nieto FJ, Tell GS (1998) Cigarette smoking and progression of atherosclerosis: the atherosclerosis risk in Communities (ARIC) study. JAMA 279(2):119–124CrossRefPubMed
77.
Zurück zum Zitat Dore MP, Malaty HM, Graham DY, Fanciulli G, Delitala G, Realdi G (2002) Risk factors associated with Helicobacter pylori infection among children in a defined geographic area. Clin Infect Dis 35(3):240–245CrossRefPubMed Dore MP, Malaty HM, Graham DY, Fanciulli G, Delitala G, Realdi G (2002) Risk factors associated with Helicobacter pylori infection among children in a defined geographic area. Clin Infect Dis 35(3):240–245CrossRefPubMed
78.
Zurück zum Zitat Fretz A, Schneider AL, McEvoy JW, Hoogeveen R, Ballantyne CM, Coresh J, Selvin E (2016) The association of socioeconomic status with subclinical myocardial damage, incident cardiovascular events, and mortality in the ARIC study. Am J Epidemiol 183(5):452–461CrossRefPubMedPubMedCentral Fretz A, Schneider AL, McEvoy JW, Hoogeveen R, Ballantyne CM, Coresh J, Selvin E (2016) The association of socioeconomic status with subclinical myocardial damage, incident cardiovascular events, and mortality in the ARIC study. Am J Epidemiol 183(5):452–461CrossRefPubMedPubMedCentral
79.
Zurück zum Zitat Palm F, Pussinen PJ, Aigner A, Becher H, Buggle F, Bauer MF, Grond-Ginsbach C, Safer A, Urbanek C, Grau AJ (2016) Association between infectious burden, socioeconomic status, and ischemic stroke. Atherosclerosis 254:117–123CrossRefPubMed Palm F, Pussinen PJ, Aigner A, Becher H, Buggle F, Bauer MF, Grond-Ginsbach C, Safer A, Urbanek C, Grau AJ (2016) Association between infectious burden, socioeconomic status, and ischemic stroke. Atherosclerosis 254:117–123CrossRefPubMed
80.
Zurück zum Zitat Lynch J, Kaplan GA, Salonen R, Cohen RD, Salonen JT (1995) Socioeconomic status and carotid atherosclerosis. Circulation 92(7):1786–1792CrossRefPubMed Lynch J, Kaplan GA, Salonen R, Cohen RD, Salonen JT (1995) Socioeconomic status and carotid atherosclerosis. Circulation 92(7):1786–1792CrossRefPubMed
81.
Zurück zum Zitat Pande RL, Creager MA (2014) Socioeconomic inequality and peripheral artery disease prevalence in US adults. Circ Cardiovasc Qual Outcomes 7(4):532–539CrossRefPubMedPubMedCentral Pande RL, Creager MA (2014) Socioeconomic inequality and peripheral artery disease prevalence in US adults. Circ Cardiovasc Qual Outcomes 7(4):532–539CrossRefPubMedPubMedCentral
82.
Zurück zum Zitat Ippoliti AF, Maxwell V, Isenberg JI (1976) The effect of various forms of milk on gastric-acid secretion. Studies in patients with duodenal ulcer and normal subjects. Ann Intern Med 84(3):286–289CrossRefPubMed Ippoliti AF, Maxwell V, Isenberg JI (1976) The effect of various forms of milk on gastric-acid secretion. Studies in patients with duodenal ulcer and normal subjects. Ann Intern Med 84(3):286–289CrossRefPubMed
83.
Zurück zum Zitat Seely S (1981) Diet and coronary disease: a survey of mortality rates and food consumption statistics of 24 countries. Med Hypotheses 7(7):907–918CrossRefPubMed Seely S (1981) Diet and coronary disease: a survey of mortality rates and food consumption statistics of 24 countries. Med Hypotheses 7(7):907–918CrossRefPubMed
84.
Zurück zum Zitat Khorsandi M, Fagin JA, Fishbein MC, Forrester JS, Cercek B (1992) Effects of hypophysectomy on vascular insulin-like growth factor-I gene expression after balloon denudation in rats. Atherosclerosis 93(1–2):115–122CrossRefPubMed Khorsandi M, Fagin JA, Fishbein MC, Forrester JS, Cercek B (1992) Effects of hypophysectomy on vascular insulin-like growth factor-I gene expression after balloon denudation in rats. Atherosclerosis 93(1–2):115–122CrossRefPubMed
85.
Zurück zum Zitat Zhao X, Yang X, Zhang X, Li Y, Zhao X, Ren L, Wang L, Gu C, Zhu Z, Han Y (2014) Dietary salt intake and coronary atherosclerosis in patients with prehypertension. J Clin Hypertens 16(8):575–580CrossRef Zhao X, Yang X, Zhang X, Li Y, Zhao X, Ren L, Wang L, Gu C, Zhu Z, Han Y (2014) Dietary salt intake and coronary atherosclerosis in patients with prehypertension. J Clin Hypertens 16(8):575–580CrossRef
86.
Zurück zum Zitat Beevers DG, Lip GY, Blann AD (2004) Salt intake and Helicobacter pylori infection. J Hypertens 22(8):1475–1477CrossRefPubMed Beevers DG, Lip GY, Blann AD (2004) Salt intake and Helicobacter pylori infection. J Hypertens 22(8):1475–1477CrossRefPubMed
87.
Zurück zum Zitat De Koster E, Buset M, Fernandes E, Deltenre M (1994) Helicobacter pylori: the link with gastric cancer. Eur J Cancer Prev 3(3):247–257CrossRefPubMed De Koster E, Buset M, Fernandes E, Deltenre M (1994) Helicobacter pylori: the link with gastric cancer. Eur J Cancer Prev 3(3):247–257CrossRefPubMed
88.
Zurück zum Zitat Antithrombotic Trialists C, Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, Buring J, Hennekens C, Kearney P, Meade T, Patrono C, Roncaglioni MC, Zanchetti A (2009) Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 373(9678):1849–1860CrossRef Antithrombotic Trialists C, Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, Buring J, Hennekens C, Kearney P, Meade T, Patrono C, Roncaglioni MC, Zanchetti A (2009) Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 373(9678):1849–1860CrossRef
89.
Zurück zum Zitat Huang JQ, Sridhar S, Hunt RH (2002) Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet 359(9300):14–22CrossRefPubMed Huang JQ, Sridhar S, Hunt RH (2002) Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet 359(9300):14–22CrossRefPubMed
90.
Zurück zum Zitat Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon AT, Bazzoli F, Gensini GF, Gisbert JP, Graham DY, Rokkas T, El-Omar EM, Kuipers EJ, European Helicobacter Study G (2012) Management of Helicobacter pylori infection--the Maastricht IV/Florence consensus report. Gut 61(5):646–664CrossRefPubMed Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon AT, Bazzoli F, Gensini GF, Gisbert JP, Graham DY, Rokkas T, El-Omar EM, Kuipers EJ, European Helicobacter Study G (2012) Management of Helicobacter pylori infection--the Maastricht IV/Florence consensus report. Gut 61(5):646–664CrossRefPubMed
91.
Zurück zum Zitat Gokturk HS, Demir M, Unler GK, Erbayrak M, Sakalli M, Yilmaz U (2011) Does long-term aspirin use have any effect on Helicobacter pylori eradication? Am J Med Sci 342(1):15–19CrossRefPubMed Gokturk HS, Demir M, Unler GK, Erbayrak M, Sakalli M, Yilmaz U (2011) Does long-term aspirin use have any effect on Helicobacter pylori eradication? Am J Med Sci 342(1):15–19CrossRefPubMed
92.
Zurück zum Zitat Chan FK, Ching JY, Suen BY, Tse YK, Wu JC, Sung JJ (2013) Effects of Helicobacter pylori infection on long-term risk of peptic ulcer bleeding in low-dose aspirin users. Gastroenterology 144(3):528–535CrossRefPubMed Chan FK, Ching JY, Suen BY, Tse YK, Wu JC, Sung JJ (2013) Effects of Helicobacter pylori infection on long-term risk of peptic ulcer bleeding in low-dose aspirin users. Gastroenterology 144(3):528–535CrossRefPubMed
93.
Zurück zum Zitat European Helicobacter Pylori Study Group (1997) Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. Gut 41(1):8–13 European Helicobacter Pylori Study Group (1997) Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. Gut 41(1):8–13
94.
Zurück zum Zitat Rosenfeld ME, Campbell LA (2011) Pathogens and atherosclerosis: update on the potential contribution of multiple infectious organisms to the pathogenesis of atherosclerosis. Thromb Haemost 106(5):858–867CrossRefPubMed Rosenfeld ME, Campbell LA (2011) Pathogens and atherosclerosis: update on the potential contribution of multiple infectious organisms to the pathogenesis of atherosclerosis. Thromb Haemost 106(5):858–867CrossRefPubMed
95.
Zurück zum Zitat Fong IW, Chiu B, Viira E, Jang D, Mahony JB (2002) Influence of clarithromycin on early atherosclerotic lesions after Chlamydia pneumoniae infection in a rabbit model. Antimicrob Agents Chemother 46(8):2321–2326CrossRefPubMedPubMedCentral Fong IW, Chiu B, Viira E, Jang D, Mahony JB (2002) Influence of clarithromycin on early atherosclerotic lesions after Chlamydia pneumoniae infection in a rabbit model. Antimicrob Agents Chemother 46(8):2321–2326CrossRefPubMedPubMedCentral
96.
Zurück zum Zitat Gupta S, Leatham EW, Carrington D, Mendall MA, Kaski JC, Camm AJ (1997) Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation 96(2):404–407CrossRefPubMed Gupta S, Leatham EW, Carrington D, Mendall MA, Kaski JC, Camm AJ (1997) Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation 96(2):404–407CrossRefPubMed
97.
Zurück zum Zitat Gurfinkel E, Bozovich G, Daroca A, Beck E, Mautner B (1997) Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study. ROXIS study group. Lancet 350(9075):404–407CrossRefPubMed Gurfinkel E, Bozovich G, Daroca A, Beck E, Mautner B (1997) Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study. ROXIS study group. Lancet 350(9075):404–407CrossRefPubMed
98.
Zurück zum Zitat Grayston JT (2003) Antibiotic treatment of atherosclerotic cardiovascular disease. Circulation 107(9):1228–1230CrossRefPubMed Grayston JT (2003) Antibiotic treatment of atherosclerotic cardiovascular disease. Circulation 107(9):1228–1230CrossRefPubMed
99.
Zurück zum Zitat Jackson LA (2000) Description and status of the azithromycin and coronary events study (ACES). J Infect Dis 181(Suppl 3):S579–S581CrossRefPubMed Jackson LA (2000) Description and status of the azithromycin and coronary events study (ACES). J Infect Dis 181(Suppl 3):S579–S581CrossRefPubMed
100.
Zurück zum Zitat O'Connor CM, Dunne MW, Pfeffer MA, Muhlestein JB, Yao L, Gupta S, Benner RJ, Fisher MR, Cook TD, Investigators in the WS (2003) Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial. JAMA 290 (11):1459–1466 O'Connor CM, Dunne MW, Pfeffer MA, Muhlestein JB, Yao L, Gupta S, Benner RJ, Fisher MR, Cook TD, Investigators in the WS (2003) Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial. JAMA 290 (11):1459–1466
101.
Zurück zum Zitat Cannon CP, Braunwald E, McCabe CH, Grayston JT, Muhlestein B, Giugliano RP, Cairns R, Skene AM, Pravastatin or Atorvastatin E, Infection Therapy-Thrombolysis in Myocardial Infarction I (2005) Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome. N Engl J Med 352(16):1646–1654CrossRefPubMed Cannon CP, Braunwald E, McCabe CH, Grayston JT, Muhlestein B, Giugliano RP, Cairns R, Skene AM, Pravastatin or Atorvastatin E, Infection Therapy-Thrombolysis in Myocardial Infarction I (2005) Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome. N Engl J Med 352(16):1646–1654CrossRefPubMed
102.
Zurück zum Zitat Jespersen CM, Als-Nielsen B, Damgaard M, Hansen JF, Hansen S, Helo OH, Hildebrandt P, Hilden J, Jensen GB, Kastrup J, Kolmos HJ, Kjoller E, Lind I, Nielsen H, Petersen L, Gluud C, Group CT (2006) Randomised placebo controlled multicentre trial to assess short term clarithromycin for patients with stable coronary heart disease: CLARICOR trial. BMJ 332(7532):22–27CrossRefPubMedPubMedCentral Jespersen CM, Als-Nielsen B, Damgaard M, Hansen JF, Hansen S, Helo OH, Hildebrandt P, Hilden J, Jensen GB, Kastrup J, Kolmos HJ, Kjoller E, Lind I, Nielsen H, Petersen L, Gluud C, Group CT (2006) Randomised placebo controlled multicentre trial to assess short term clarithromycin for patients with stable coronary heart disease: CLARICOR trial. BMJ 332(7532):22–27CrossRefPubMedPubMedCentral
Metadaten
Titel
Helicobacter pylori infection and atherosclerosis: is there a causal relationship?
verfasst von
Z. Xu
J. Li
H. Wang
G. Xu
Publikationsdatum
27.07.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 12/2017
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-017-3054-0

Weitere Artikel der Ausgabe 12/2017

European Journal of Clinical Microbiology & Infectious Diseases 12/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.